DexCom, Inc. DXCM
Analyst Consensus
Price Objectif
Analyst historical
| Analyst | Entreprise | Price during analysis | Target price | Potential gain | Publication date |
|---|---|---|---|---|---|
| Jonathan Block | Stifel Nicolaus | 72.59 $ | 90 $ | 17.41 % | 05/06/2026 |
| Matt Miksic | Barclays | 61.63 $ | 64 $ | 2.37 % | 18/05/2026 |
| Anthony Petrone | Mizuho Securities | 61.65 $ | 75 $ | 13.35 % | 01/05/2026 |
| Anthony Petrone | Mizuho Securities | 65.08 $ | 90 $ | 24.92 % | 13/02/2026 |
| Mike Kratky | Leerink Partners | 65.3762 $ | 92 $ | 26.62 % | 16/12/2025 |
| Patrick Wood | Morgan Stanley | 63.52 $ | 75 $ | 11.48 % | 02/12/2025 |
| Lee Hambright | Bernstein | 58.22 $ | 84 $ | 25.78 % | 03/11/2025 |
| Matt O'Brien | Piper Sandler | 56.97 $ | 75 $ | 18.03 % | 31/10/2025 |
| William Plovanic | Canaccord Genuity | 68.2 $ | 99 $ | 30.80 % | 31/10/2025 |
| Matt O'Brien | Piper Sandler | 68.4446 $ | 100 $ | 31.56 % | 21/10/2025 |
| Richard Newitter | Truist Financial | 65.55 $ | 94 $ | 28.45 % | 15/10/2025 |
| Shagun Singh | RBC Capital | 68.62 $ | 120 $ | 51.38 % | 08/10/2024 |
| Mathew Blackman | Stifel Nicolaus | 72.28 $ | 100 $ | 27.72 % | 22/08/2024 |
| Shagun Singh | RBC Capital | 72.36 $ | 130 $ | 57.64 % | 16/08/2024 |
| Matt Miksic | Barclays | 64 $ | 113 $ | 49.00 % | 29/07/2024 |
| Steven Lichtman | Oppenheimer | 107.85 $ | 115 $ | 7.15 % | 26/07/2024 |
| Matt O\'Brien | Piper Sandler | 63.22 $ | 90 $ | 26.78 % | 26/07/2024 |
| William Plovanic | Canaccord Genuity | 107.85 $ | 89 $ | -18.85 % | 26/07/2024 |
| Shagun Singh | RBC Capital | 31.77 $ | 145 $ | 113.23 % | 26/07/2024 |
| Mathew Blackman | Stifel Nicolaus | 112.66 $ | 132 $ | 19.34 % | 12/07/2024 |
| Steven Lichtman | Oppenheimer | 115.23 $ | 150 $ | 34.77 % | 03/06/2024 |
| Issie Kirby | Redburn Partners | 127.64 $ | 130 $ | 2.36 % | 30/05/2024 |
| Shagun Singh | RBC Capital | 134.475 $ | 165 $ | 30.53 % | 12/03/2024 |
| Steven Lichtman | Oppenheimer | 88.91 $ | 122 $ | 33.09 % | 27/10/2023 |
| Stifel Stifel | Stifel Nicolaus | 111.44 $ | 130 $ | 18.56 % | 26/12/2022 |
| Matt O'Brien | Piper Sandler | 95.21 $ | 120 $ | 24.79 % | 07/10/2022 |
| Matt O'Brien | Piper Sandler | 86.99 $ | 110 $ | 23.01 % | 28/07/2022 |
| Lee Hambright | Bernstein | 76.5 $ | 105 $ | 28.50 % | 15/07/2022 |
| Marie Thibault | BTIG | 76.6 $ | 105 $ | 28.40 % | 28/06/2022 |
| Mathew Blackman | Stifel Nicolaus | 24.7925 $ | 520 $ | 495.21 % | 03/05/2022 |
| Danielle Antalffy | Leerink Partners | 24.7925 $ | 500 $ | 475.21 % | 03/05/2022 |
| Marie Thibault | BTIG | 31.024375 $ | 560 $ | 528.98 % | 21/04/2022 |
| Travis Steed | Bank of America Securities | 26.496875 $ | 500 $ | 473.50 % | 03/03/2022 |
| Joanna Wuensch | Citigroup | 26.285 $ | 630 $ | 603.72 % | 11/02/2022 |
| Steven Lichtman | Oppenheimer | 26.905 $ | 580 $ | 553.10 % | 31/01/2022 |
| Larry Biegelsen | Wells Fargo | 27.201875 $ | 575 $ | 547.80 % | 19/01/2022 |
| Jayson Bedford | Raymond James | 27.201875 $ | 538 $ | 510.80 % | 19/01/2022 |
| Matthew Taylor | UBS | 38.950625 $ | 660 $ | 621.05 % | 29/10/2021 |
| Ravi Misra | Berenberg Bank | 38.950625 $ | 630 $ | 591.05 % | 29/10/2021 |
| Anthony Petrone | Jefferies | 38.950625 $ | 655 $ | 616.05 % | 29/10/2021 |
| Kyle Rose | Canaccord Genuity | 38.950625 $ | 625 $ | 586.05 % | 29/10/2021 |
| Chris Cooley | Stephens | 32.219375 $ | 546 $ | 513.78 % | 30/07/2021 |
| Robbie Marcus | J.P. Morgan | 24.376875 $ | 450 $ | 425.62 % | 09/06/2021 |